- Home
- CALC
CALC
CalciMedica Inc.
as of 12-09-2025 4:00pm EST
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | 63.0M | IPO Year: | N/A |
| Target Price: | $14.50 | AVG Volume (30 days): | 106.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.42 - $4.82 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered CALC Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of CalciMedica Inc. (CALC)
CHIEF BUSINESS OFFICER
Avg Cost/Share
$3.07
Shares
2,500
Total Value
$7,675.00
Owned After
84,150
SEC Form 4
CHIEF BUSINESS OFFICER
Avg Cost/Share
$2.68
Shares
3,400
Total Value
$9,104.86
Owned After
84,150
SEC Form 4
CHIEF BUSINESS OFFICER
Avg Cost/Share
$3.12
Shares
5,000
Total Value
$15,600.00
Owned After
84,150
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Roberts Eric W | CALC | CHIEF BUSINESS OFFICER | Sep 18, 2025 | Buy | $3.07 | 2,500 | $7,675.00 | 84,150 | |
| Roberts Eric W | CALC | CHIEF BUSINESS OFFICER | Sep 15, 2025 | Buy | $2.68 | 3,400 | $9,104.86 | 84,150 | |
| Roberts Eric W | CALC | CHIEF BUSINESS OFFICER | Sep 12, 2025 | Buy | $3.12 | 5,000 | $15,600.00 | 84,150 |
Compare CALC vs Leading Stocks
See how CALC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CALC CalciMedica Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.